The article examines the cost of poor sponsor-site relationships and urges sponsors to change their mindset and fix communication problems.
Needham, MA (PRWEB) January 10, 2014
Platforms like TrialNetworks’ unique Clinical Trial Optimization System can be used by pharmaceutical companies to improve sponsor-site relations, says TrialNetworks client Steven P. Sweeney, Vice President and Head of Clinical Development Operations for Arteaus Therapeutics, in a new article published by the Journal for Clinical Research Best Practices.
The article, “Treat Your Sites Like Customers... and Use Technology to Help Do It,” examines the cost of poor sponsor-site relationships and urges sponsors to change their mindset and fix communication problems. Steve says that sponsors can leverage solutions such as the exclusive TrialNetworks platform to keep sites engaged through consistent communication strategies, online training apps, helpful visit guides, support tools, and more. Topics covered include:
- How to assess your current communication practices
- An overview of clinical trial portals and communication platforms
- Functions that can be improved by such technology
- Site adoption case study during a 13-month trial
TrialNetworks Co-Founder and CEO Eric Silberstein said, “Steve Sweeney is a visionary clinical research executive with whom we have had the pleasure of working for several years on multiple trials. We share his passion for site advocacy and his belief that technology platforms like ours help innovative sponsors improve site communications and relationships. We admire and congratulate him for sharing his experiences and advice on how to radically improve clinical trial operations in this important article.”
To discover how the TrialNetworks platform is revolutionizing clinical trial optimization, request a demo at http://www.trialnetworks.com.
TrialNetworks, co-founded by U.S. Surgeon General nominee Dr. Vivek Murthy, provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using this modern and intuitive technology, customers such as Merck & Co., Biogen Idec and Infinity Pharmaceuticals are able to transform the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface.
Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at http://www.trialnetworks.com.